The epidemiological data suggest that brain insulin resistance flanks both cognitive decline and progressive neuroinflammation in neurodegenerative diseases [11]; in particular, type II diabetes represent a risk factor to develop Alzheimer’s disease [24-28]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.